Reviewing Extractables Information for Single-Use Equipment in Peptide API Manufacturing

Single-use bags, tubing, filters, and connectors are common in peptide API manufacturing, particularly in buffer preparation, filtration, and bulk holding. Procurement and QA teams are increasingly asked how to review extractables information for single-use equipment in peptide API manufacturing. This article explains what the documentation typically contains, how to interpret it in context, and which questions to direct to the peptide supplier versus the component vendor. It does not establish safety thresholds, which depend on your product and route of administration.

Start by clarifying scope. The peptide supplier should identify which single-use components contact the process stream, at which steps, and for how long. A component used for buffer preparation has a different contact profile from one used to hold purified bulk. Ask for a component-by-component list with material of construction, vendor, and contact conditions. Without this map, extractables data cannot be interpreted meaningfully, and the review becomes a document collection exercise rather than a risk assessment.

Next, examine the source of the extractables data. Component vendors typically provide extractables studies performed under controlled laboratory conditions with specified solvents, temperatures, and contact times. Ask whether the study conditions are relevant to your actual process. A study using aggressive solvents at elevated temperature may overestimate or underestimate what occurs in an aqueous buffer at ambient conditions. The peptide supplier should be able to explain the relevance rather than simply forwarding vendor reports.

Review the analytical methods used in the extractables study. Common techniques include gas chromatography with mass spectrometric detection, liquid chromatography with mass spectrometric detection, and inductively coupled plasma methods for elemental impurities. Ask which techniques were applied and whether the study covered volatile, semi-volatile, non-volatile, and elemental species. A study limited to one technique may leave gaps. You do not need to validate the vendor's methods, but you should understand what was and was not detected.

Consider how the peptide supplier has assessed risk. A credible approach links each identified extractable to a toxicological evaluation and to the actual contact conditions. Ask whether the supplier has performed a toxicological risk assessment for the components used in your process and whether any compounds were flagged for further evaluation. Confirm that the assessment considers accumulation over multiple unit operations and, where relevant, the effect of repeated use of the same component type.